Table 1.
Factor | Missing n (%) | |
---|---|---|
Mean (SD) age, years | 47.0 (25.1) | 0 |
Range | 0–99 | |
Sex | ||
Female | 2349 (47.3) | 0 |
Male | 2616 (52.7) | |
ASA physical status | ||
1 | 986 (19.9) | 0 |
2 | 2217 (44.7) | |
3 | 1579 (31.8) | |
4 | 183 (3.7) | |
Ethnicity | 283 (6.0) | |
White | 3263 (69.7) | |
Asian | 441 (9.4) | |
ATSI | 25 (0.5) | |
Black/African | 50 (1.1) | |
Other | 903 (19.3) | |
Socio‐economic classification (IRSAD) | 23 (0.5) | |
1–20% | 604 (12.2) | |
21–40% | 763 (15.4) | |
41–60% | 915 (18.5) | |
61–80% | 1072 (21.7) | |
81–100% | 1588 (32.1) | |
Comorbidities | ||
CVD (including HT, HF, CAD) | 1766 (35.6) | 2 (0.0) |
Treated diabetes | 642 (12.9) | 2 (0.0) |
COPD and/or asthma | 771 (15.5) | 2 (0.0) |
Month of surgery | 5 (0.1) | |
July | 1302 (26.3) | |
August | 3658 (73.8) | |
Preoperative screening on admission | 4618 (93.3) | 14 (0.3) |
Temperature check on admission | 4861 (98.0) | 4 (0.1) |
Overseas travel in 2020 | 27 (0.6) | 623 (14.3) |
When was travel | 5 (19) | 0 |
≤2 weeks | 22 (81) | |
>2 weeks | ||
COVID‐19 contact | 13 (0.3) | 16 (0.3) |
When was contact | 0 | |
≤2 weeks | 9 (69) | |
>2 weeks | 4 (31) | |
Health worker | 136 (2.7) | 3 (0.1) |
Surgery type | 3 (0.1) | |
Orthopaedic | 381 (7.7) | |
Urology | 697 (14.0) | |
Gynaecological | 361 (7.3) | |
Gastrointestinal | 536 (10.8) | |
Plastics | 415 (8.4) | |
Neurological | 155 (3.1) | |
Cardiac | 201 (4.1) | |
Vascular | 127 (2.6) | |
Ear, nose, throat | 286 (5.8) | |
Endoscopy | 952 (19.2) | |
Ophthalmology | 59 (1.2) | |
Oral/faciomaxillary | 61 (1.2) | |
Other | 731 (14.7) | |
Unplanned ICU/HDU admission | 36(0.07) | 32 (0.6) † |
Hospital stay | 7 (0.1) † | |
≥1 night stay | 2112 (42.6) | |
Day case | 2846 (57.4) | |
Number of nights in hospital, median (IQR) | 2.0 (1.0. 5.0) | 34 (1.6) † |
In‐hospital mortality | 10 (0.2) | 37 (0.8) † |
Data are represented as number (%), unless otherwise indicated.
Patients still as inpatients on 22 September 2020.
ASA, American Society of Anesthesiologists; ATSI, Aboriginal or Torres Strait Islander; CAD, coronary artery disease; COPD, chronic obstructive pulmonary disease; CVD, cardiovascular disease; HDU, high‐dependency unit; HF, heart failure; HT, hypertension; ICU, intensive care unit; IQR, interquartile range; IRSAD, Index of Relative Socio‐economic Advantage and Disadvantage.